Repaglinide
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 900 publications
Helicobacter pylori Eradication Therapy-induced Severe Hypoglycemia in a Hemodialysis Patient with Type 2 Diabetes Mellitus.
Journal: Internal medicine (Tokyo, Japan)
Published: March 11, 2026
Pharmacokinetic and Bioequivalence Evaluation of Two Repaglinide Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.
Journal: Clinical pharmacology in drug development
Published: January 06, 2026
Biodistribution of Cerivastatin, Repaglinide, Glyburide, Rosuvastatin, and Valsartan in Cynomolgus Monkeys and PBPK Analysis.
Journal: The AAPS journal
Published: December 02, 2025
Noninsulin drugs for type 2 diabetes.
Journal: The Medical letter on drugs and therapeutics
Published: November 19, 2025
Corrigendum to "Human cytochrome P4502C8 metabolizes repaglinide to 4'-hydroxyrepaglinide, not 3'-hydroxyrepaglinide" [Drug Metabolism and Disposition 53 (2025) 100177].
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: November 13, 2025
LC-MS/MS-based investigation of pharmacokinetic interactions between CYP3A4 substrates enzalutamide and repaglinide in rats.
Journal: Analytical methods : advancing methods and applications
Published: October 31, 2025
Correction: Ahmad et al. Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes. Biomedicines 2023, 11, 1064.
Journal: Biomedicines
Published: October 03, 2025
Human cytochrome P4502C8 metabolizes repaglinide to 4'-hydroxyrepaglinide, not 3'-hydroxyrepaglinide.
Journal: Drug metabolism and disposition: the biological fate of chemicals
Published: August 25, 2025
Dietary Modulation of CYP3A4 and Its Impact on Statins and Antidiabetic Drugs: A Narrative Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 30, 2025
Chitosan-based hydrogels loaded with repaglinide and difluorinated curcumin: impact on structural integrity, drug release, and antibacterial activity.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: July 12, 2025
Effect of Oral Hypoglycaemic Agents on Carotid Artery Intima-Media Thickness in Patients With Cardiovascular Disease and/or Diabetes-A Systematic Review.
Journal: Endocrinology, diabetes & metabolism
Published: July 10, 2025
Last Updated: 04/28/2026